Navigation Links
Auxogyn And Reproductive Medicine Associates of New Jersey Partner To Advance in vitro fertilization Research
Date:6/19/2012

MENLO PARK, Calif., June 19, 2012 /PRNewswire/ -- Auxogyn, Inc., a company at the forefront of reproductive health innovation, today announced the commencement of a groundbreaking research study with Reproductive Medicine Associates of New Jersey (RMANJ), an internationally-renowned fertility clinic that has pioneered and successfully implemented cutting-edge clinical advancements to more accurately detect healthy embryos for patients undergoing in vitro fertilization (IVF).

(Logo: http://photos.prnewswire.com/prnh/20120605/SF18545LOGO)

"Auxogyn is committed to funding and conducting rigorous scientific research to continually improve outcomes for IVF patients," said Lissa Goldenstein, president and chief executive officer of Auxogyn. "We are pleased to partner with RMANJ and believe this study may expand our understanding of embryo development dramatically, potentially leading to further improvement in our ability to detect healthy embryos during assisted reproduction procedures."

Patients enrolled in the study will be those who have determined, after consultation with their physician, to undergo pre-implantation genetic diagnosis using Comprehensive Chromosome Screening (CCS), a new rapid-method 24-chromosome screening technique first implemented at RMANJ. During the study, all embryos will be monitored using the Eeva™ (Early Embryo Viability Assessment) Test, a non-invasive test developed by Auxogyn to record and quantitatively analyze embryo development against scientifically- and clinically-validated cell-division time periods.

"Our objectives at RMANJ are two-fold: to increase the healthy live birth rate for those undergoing assisted reproductive procedures, and to decrease the multiple embryo transfer rate, thereby reducing multiple pregnancies," commented Richard T. Scott, Jr., M.D., F.A.C.O.G., H.C.L.D., founding partner of RMANJ. "T
'/>"/>

SOURCE Auxogyn, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Auxogyn Completes $20 Million In Series A Funding
2. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
3. Alliance for Safe Biologic Medicines Chairman Urges FDA to Ensure that Patient Safety is the Cornerstone of Biosimilar Pathway
4. First targeted and programmable nanomedicine to show clinical antitumor effects published
5. CNIO researchers take part in the most comprehensive personalized medicine study performed to date
6. Dr. Alan Gaby to Present Nutritional Medicine Updates in a Nationwide Tour
7. Smart, self-healing hydrogels open far-reaching possibilities in medicine, engineering
8. New Study Building Framework to Bring Personalized Medicine to the Clinic
9. bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation
10. Palm Beach Residents to Learn How the Future of Regenerative Medicine Will Combat Aging
11. PinneyAssociates Announces Senior Staff Promotions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 Vital Imaging ™ has ... California, San Diego for a joint study which aims ... (Magnetic Resonance Imaging) with that of a supine Dynawell ... pursuit of improved healthcare by combining cutting edge technology ... extremely valuable tool for evaluating pathological changes in the ...
(Date:5/21/2013)... SoundConnect is pleased to announce the release ... in Canada. Lync is the next generation of ... and organizations to collaborate and communicate much more easily ... the United States. With the progressive rollout of Lync ... Canada, SoundConnect now offers a complete Microsoft Lync solution ...
(Date:5/21/2013)... May 21, 2013 The Formulate Fusion ... solution for sales and marketing teams looking for a fully-functional ... the kit as “everything you’ll need to put together a ... Kit comes with a number of displays and accessories that ... 20 feet by 20 feet in size. These components vary ...
(Date:5/20/2013)... May 20, 2013 , ... Research Service (ARS) in treatment of mastitis ... , Trials to begin in the second half ... technology company Phosphagenics Limited (ASX: POH, OTCQX: ... (USDA) Agricultural Research Service (ARS) to develop and trial ...
Breaking Biology Technology:Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2Phosphagenics Signs Research Agreement with the Agricultural Research Service 2
... Elekta, a global leader in radiation,oncology and ... at the 49th Annual Meeting of The American ... reduce,treatment times and increase efficiency. The meeting will ... Los Angeles Convention Center (Los Angeles,California, USA). Elekta ...
... N.J., Oct. 18 NPS,Pharmaceuticals, Inc. (Nasdaq: NPSP ... cash tender offer for any and all of its ... at midnight, New,York City time, on October 17, 2007. ... offer, $171.2 million principal,amount of the notes, representing approximately ...
... Glycominds Ltd., a,biodiagnostics company specializing in glycan biomarkers ... cancer, announced today the,appointment of Dr. Chen Even ... Chen, a board member since 2004, contributes more ... "We are very pleased to elevate Dr. Even ...
Cached Biology Technology:Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007 2Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007 3Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007 4NPS Pharmaceuticals Announces Results of Tender Offer 2NPS Pharmaceuticals Announces Results of Tender Offer 3Glycominds Appoints Board of Directors Chairman 2Glycominds Appoints Board of Directors Chairman 3
(Date:5/21/2013)... Chicago College of Medicine will study gender differences in how ... source -- and how changes in fat metabolism play a ... grant from the National Heart, Lung and Blood Institute. , ... energy. These changes may play a major role in the ... women, says E. Douglas Lewandowski, director of the UIC Center ...
(Date:5/21/2013)... Where? Copenhagen, Denmark: Bella Center Congress Centre ... , Why? An annual meeting focusing ... manufacturing and installation, drawing on leading experiences from all ... from a record of more than 900 abstracts received ... and oral presentations, more than 460 visual presentation, 55 ...
(Date:5/20/2013)... the antibiotic colistin are also commonly resistant to ... to a study in mBio , the ... Microbiology. Cross-resistance to colistin and host antimicrobials LL-37 ... bacterial attack, could mean that patients with life-threatening ... crippled immune response. Colistin is a last-line drug ...
Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... A new study from The Montreal Neurological Institute and Hospital ... to discover a molecular link between Parkinson,s disease and defects ... published in the prestigious journal Molecular Cell and ... , provides new insight into the mechanisms underlying Parkinson,s disease, ...
... the molecular process that can shut down a marauding, ... who suffer battlefield casualties, heart attacks, strokes, automobile accidents ... the January edition of Molecular Immunology. , The ... of a reaction first observed in the lab by ...
... Diseases (NIAID), part of the National Institutes of Health ... Tulane University for its ongoing efforts to treat and ... threatens hundreds of thousands of people annually in West ... The contract will include collaboration between Tulane; Scripps ...
Cached Biology News:Communication breakdown: what happens to nerve cells in Parkinson's disease 2Communication breakdown: what happens to nerve cells in Parkinson's disease 3Research could lead to way to halt deadly immune response 2Research could lead to way to halt deadly immune response 3Tulane receives $15 million NIH contract to develop vaccine and treatment for deadly fever 2
Peptide-affinity Purified Polyclonal Antibody to MTR...
Purified anti-eIF-4E...
Purified anti-PXR...
Goat polyclonal to MLH3 ( Abpromise for all tested applications). entrezGeneID: 27030 SwissProtID: Q9UHC1...
Biology Products: